These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10581980)

  • 1. Five cases of interferon-alpha-induced depression treated with antidepressant therapy.
    Gleason OC; Yates WR
    Psychosomatics; 1999; 40(6):510-2. PubMed ID: 10581980
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirtazapine for the treatment of interferon-induced psychopathology.
    Russo S; Boon JC; Korf J; Haagsma EB
    Gen Hosp Psychiatry; 2003; 25(6):497. PubMed ID: 14706418
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 4. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
    Kajitani K; Kanba S
    Psychosomatics; 2013; 54(5):506-7. PubMed ID: 23845321
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-induced depression treated with citalopram.
    Farah A
    J Clin Psychiatry; 2002 Feb; 63(2):166-7. PubMed ID: 11874221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacologic treatment of depression].
    Woggon B
    Ther Umsch; 2000 Feb; 57(2):81-9. PubMed ID: 10730102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressants.
    Salzman C
    Clin Geriatr Med; 1990 May; 6(2):399-410. PubMed ID: 2184931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
    Lang JP; Meyer N; Doffoel M
    Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of carbamazepine combined with an ineffective antidepressant. Apropos of 4 cases].
    Navarre C; Maurin C; Colonna L
    Encephale; 1994; 20(1):79-80. PubMed ID: 8174514
    [No Abstract]   [Full Text] [Related]  

  • 13. Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.
    Galvão-de Almeida A; Guindalini C; Batista-Neves S; de Oliveira IR; Miranda-Scippa A; Quarantini LC
    Gen Hosp Psychiatry; 2010; 32(4):401-5. PubMed ID: 20633744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
    Chapman J; Oser M; Hockemeyer J; Weitlauf J; Jones S; Cheung R
    Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 16. [Depressive disorders and interferon alpha].
    Hardy P
    Gastroenterol Clin Biol; 1996; 20(3):255-7. PubMed ID: 8763063
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
    Nickel T; Sonntag A; Backmund M; Pollmächer T
    Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine for treatment of interferon alfa-induced depression.
    Malek-Ahmadi P; Prabhu F
    Ann Pharmacother; 2006 Nov; 40(11):2075. PubMed ID: 17047142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Viral hepatitis B/C and HIV. Therapy of double infections].
    Mauss S
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychiatric side effects during adjuvant therapy with interferon-alphain patients with malignant melanoma. Clinical evaluation as well as diagnostic and therapeutic possibilities].
    Schäfer M; Messer T; Wegner U; Schmid-Wendtner MH; Volkenandt M
    Hautarzt; 1999 Sep; 50(9):654-8. PubMed ID: 10501682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.